APA (7th ed.) Citation

Kittipibul, V., Mentz, R. J., Young, R., Butler, J., Ezekowitz, J. A., Lam, C. S., . . . Group, f. t. V. S. (2025, April). Projecting the benefit of vericiguat in PARADIGM‐HF and DAPA‐HF populations: Insights from the VICTORIA trial. ESC Heart Failure.

Chicago Style (17th ed.) Citation

Kittipibul, Veraprapas, et al. "Projecting the Benefit of Vericiguat in PARADIGM‐HF and DAPA‐HF Populations: Insights from the VICTORIA Trial." ESC Heart Failure Apr. 2025.

MLA (9th ed.) Citation

Kittipibul, Veraprapas, et al. "Projecting the Benefit of Vericiguat in PARADIGM‐HF and DAPA‐HF Populations: Insights from the VICTORIA Trial." ESC Heart Failure, Apr. 2025.